1 Undervalued Stock Set for a Comeback and 2 We Overlook

Stocks Reaching New Lows: Turning Points or Trouble?

When a stock hits its lowest point in a year, it can signal a critical juncture—either the start of a recovery or a sign of deeper challenges ahead.

Although timing the market can yield impressive gains, it’s a risky approach that demands thorough research and expertise—something we focus on at StockStory. Below, we highlight one stock that stands out as a buying opportunity, along with two others where caution is justified.

Stocks to Consider Selling

Merit Medical Systems (MMSI)

One-Month Performance: -5.1%

Since its founding in 1987, Merit Medical Systems (NASDAQ:MMSI) has grown to offer more than 1,700 patented products worldwide. The company specializes in developing and distributing medical devices for minimally invasive procedures in fields such as cardiology, radiology, oncology, critical care, and endoscopy.

Reasons for Concern with MMSI:

• The company’s annual revenue of $1.52 billion is relatively modest, limiting its ability to leverage fixed costs and expand distribution compared to larger competitors.
• Returns on capital have lagged, suggesting management has struggled to identify attractive investment opportunities.

Currently, Merit Medical Systems trades at $78.29 per share, with a forward price-to-earnings ratio of 20.3.

PennyMac Financial Services (PFSI)

One-Month Performance: -39.2%

PennyMac Financial Services (NYSE:PFSI) was established during the 2008 financial crisis to address turmoil in the mortgage sector. The company focuses on originating, servicing, and managing investments tied to residential mortgages in the U.S.

Why We Advise Caution with PFSI:

• Revenue has declined by an average of 10.4% per year over the past five years, indicating unfavorable market conditions.
• Net interest income grew at just 7.1% annually during the same period, trailing the industry average for banks.
• Earnings per share have fallen by 10% each year over the last five years, which often leads to weaker long-term stock performance.

PennyMac Financial Services is currently priced at $92.45 per share, with a forward price-to-book ratio of 1.

Stock to Watch: A Potential Buy

Progressive (PGR)

One-Month Performance: -1.7%

Founded in 1937 with a focus on insuring high-risk drivers, Progressive (NYSE:PGR) has evolved into a leading provider of auto, property, and commercial insurance. The company distributes its policies through independent agents, online channels, and phone support.

Why Progressive Stands Out:

• Net premiums earned have climbed by 18% per year over the last two years, reflecting strong market share growth.
• Recent sales growth has been highly profitable, with earnings per share rising 72.1% annually—outpacing revenue gains.
• The company’s capital position is expected to strengthen, with book value per share projected to increase by 29.7% over the next year, suggesting profitability will accelerate.

At $204.55 per share, Progressive trades at 3.2 times its forward book value. Is this the right moment to invest?

Top-Quality Stocks for Every Market Environment

Despite a strong market rally this year, just four stocks are responsible for half of the S&P 500’s total gains—a level of concentration that can make investors uneasy. While many flock to popular names, savvy investors are seeking out overlooked, high-quality companies trading at attractive valuations. Discover our handpicked selections in the Top 6 Stocks for this week, a curated list of high-quality stocks that have delivered a remarkable 244% return over the past five years (as of June 30, 2025).

Our 2020 picks included now-prominent companies like Nvidia, which soared 1,326% from June 2020 to June 2025, as well as lesser-known firms such as Kadant, which achieved a 351% five-year return. Start your search for the next standout performer with StockStory today.